308 related articles for article (PubMed ID: 34234432)
1. Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels.
Cunha S; Forbes B; Sousa Lobo JM; Silva AC
Int J Nanomedicine; 2021; 16():4373-4390. PubMed ID: 34234432
[TBL] [Abstract][Full Text] [Related]
2. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies.
Cunha S; Swedrowska M; Bellahnid Y; Xu Z; Sousa Lobo JM; Forbes B; Silva AC
Int J Pharm; 2022 May; 620():121720. PubMed ID: 35413397
[TBL] [Abstract][Full Text] [Related]
3. In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model.
Pina Costa C; Nižić Nodilo L; Silva R; Martins E; Zadravec D; Kalogjera L; Nuno Moreira J; Manuel Sousa Lobo J; Hafner A; Catarina Silva A
Int J Pharm; 2023 Sep; 644():123345. PubMed ID: 37619806
[TBL] [Abstract][Full Text] [Related]
4. Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease.
Akel H; Ismail R; Csóka I
Eur J Pharm Biopharm; 2020 Mar; 148():38-53. PubMed ID: 31926222
[TBL] [Abstract][Full Text] [Related]
5. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
Jojo GM; Kuppusamy G; De A; Karri VVSNR
Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
[TBL] [Abstract][Full Text] [Related]
6. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
[TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of
Costa CP; Moreira JN; Sousa Lobo JM; Silva AC
Acta Pharm Sin B; 2021 Apr; 11(4):925-940. PubMed ID: 33996407
[TBL] [Abstract][Full Text] [Related]
8. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis.
Costa C; Moreira JN; Amaral MH; Sousa Lobo JM; Silva AC
J Control Release; 2019 Feb; 295():187-200. PubMed ID: 30610952
[TBL] [Abstract][Full Text] [Related]
9. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
10. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics.
Wavikar P; Pai R; Vavia P
J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321
[TBL] [Abstract][Full Text] [Related]
11. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Administration of chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease.
Gartziandia O; Herrán E; Ruiz-Ortega JA; Miguelez C; Igartua M; Lafuente JV; Pedraz JL; Ugedo L; Hernández RM
J Biomed Nanotechnol; 2016 Dec; 12(12):2220-30. PubMed ID: 29372975
[TBL] [Abstract][Full Text] [Related]
13. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
[TBL] [Abstract][Full Text] [Related]
14. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
[TBL] [Abstract][Full Text] [Related]
15. Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery.
Wavikar PR; Vavia PR
J Liposome Res; 2015; 25(2):141-9. PubMed ID: 25203610
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain.
Matarazzo AP; Elisei LMS; Carvalho FC; Bonfílio R; Ruela ALM; Galdino G; Pereira GR
Eur J Pharm Sci; 2021 Apr; 159():105698. PubMed ID: 33406408
[TBL] [Abstract][Full Text] [Related]
17. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
18. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin.
Fahmy UA; Ahmed OAA; Badr-Eldin SM; Aldawsari HM; Okbazghi SZ; Awan ZA; Bakhrebah MA; Alomary MN; Abdulaal WH; Medina C; Alhakamy NA
Int J Nanomedicine; 2020; 15():5253-5264. PubMed ID: 32801690
[TBL] [Abstract][Full Text] [Related]
19. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
[TBL] [Abstract][Full Text] [Related]
20. In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization.
Rajput A; Bariya A; Allam A; Othman S; Butani SB
Drug Deliv Transl Res; 2018 Oct; 8(5):1460-1470. PubMed ID: 29785574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
